Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 07:15PM GMT
Release Date Price: $146.49 (+8.97%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Hey. Good afternoon, everyone. My name is Jess Fye. I'm one of the Senior Biotech Analyst at JPMorgan, and we're continuing the 40th Annual Healthcare Conference today with Jazz Pharmaceuticals.

I'm joined by the company's Chairman and CEO, Bruce Cozadd, who is going to give a presentation followed by a Q&A session. If you want to ask a question during the Q&A, use the blue ask question button on your screen, that will send it to me through the portal and I can ask management after the presentation.

So with that out of the way, let me turn it over to Bruce.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

All right. Thanks, Jess, and thanks, everyone, for joining us. I hope you're all well. I'm excited to be at my 31st consecutive JPMorgan Healthcare Conference, where today I have the privilege of sharing an update on the significant accomplishments and my excitement about the future of Jazz Pharmaceuticals.

In 2021, thanks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot